Hattori Y, Tashiro H, Kawamoto T, Kodama Y
Safety and Environment Department, Yawata Works, Nippon Steel Corporation, Kitakyushu.
Jpn J Cancer Res. 1995 Dec;86(12):1210-5. doi: 10.1111/j.1349-7006.1995.tb03317.x.
The aim of this study was to estimate the validity of mass screening for gastric cancer using serum pepsinogens (PG test). The study subjects were 4876 workers aged from 40 to 61 years old. Sera were obtained at the time of the health checkup and serum pepsinogen levels (PG I and PG II) were measured at the same time. PG I < 50 ng/ml and PG I/PG II ratio < 3.0 were adopted as the criteria for a positive result for the PG test. PG test-positive subjects were examined, in principle, by endoscopy. Furthermore, all subjects were followed up for a year to check for occurrence of gastric cancer. Among the total subjects, 911 (18.7%) were positive for the PG test and 650 (71.4%) among the positive subjects underwent further examinations, which revealed 11 cases of gastric cancer. Seven gastric cancer cases were diagnosed during the follow-up period within one year after the PG test. When the results of one years's follow-up from the time of screening were defined as the gold standard, the sensitivity and specificity of the PG test were estimated at 66.7% and 81.5%, respectively. The authors conclude that the validity of the PG test as a mass screening method may be comparable to that of X-ray screening, if optimum criteria of a positive test are selected.
本研究的目的是评估使用血清胃蛋白酶原(PG检测)进行胃癌大规模筛查的有效性。研究对象为4876名年龄在40至61岁之间的工人。在健康检查时采集血清,并同时检测血清胃蛋白酶原水平(PG I和PG II)。PG I < 50 ng/ml且PG I/PG II比值 < 3.0被用作PG检测阳性结果的标准。原则上,对PG检测呈阳性的受试者进行内镜检查。此外,对所有受试者进行了为期一年的随访,以检查胃癌的发生情况。在所有受试者中,911人(18.7%)PG检测呈阳性,其中650名阳性受试者(71.4%)接受了进一步检查,发现了11例胃癌。在PG检测后的一年内随访期间诊断出7例胃癌。以筛查时一年的随访结果为金标准,PG检测的敏感性和特异性分别估计为66.7%和81.5%。作者得出结论,如果选择最佳的阳性检测标准,PG检测作为一种大规模筛查方法的有效性可能与X射线筛查相当。